These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25448765)

  • 1. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
    Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
    Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
    Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
    J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
    Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
    Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
    Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
    Chapouly C; Tadesse Argaw A; Horng S; Castro K; Zhang J; Asp L; Loo H; Laitman BM; Mariani JN; Straus Farber R; Zaslavsky E; Nudelman G; Raine CS; John GR
    Brain; 2015 Jun; 138(Pt 6):1548-67. PubMed ID: 25805644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
    Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
    Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
    [No Abstract]   [Full Text] [Related]  

  • 9. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
    Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA
    Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis.
    Wolburg-Buchholz K; Mack AF; Steiner E; Pfeiffer F; Engelhardt B; Wolburg H
    Acta Neuropathol; 2009 Aug; 118(2):219-33. PubMed ID: 19533155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
    Soon D; Tozer D; Altmann D; Tofts P; Miller D
    Mult Scler; 2007 Aug; 13(7):884-94. PubMed ID: 17468443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.
    Larochelle C; Lécuyer MA; Alvarez JI; Charabati M; Saint-Laurent O; Ghannam S; Kebir H; Flanagan K; Yednock T; Duquette P; Arbour N; Prat A
    Ann Neurol; 2015 Jul; 78(1):39-53. PubMed ID: 25869475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-brain barrier in cortical multiple sclerosis lesions.
    van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
    Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
    Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
    Huppert J; Closhen D; Croxford A; White R; Kulig P; Pietrowski E; Bechmann I; Becher B; Luhmann HJ; Waisman A; Kuhlmann CR
    FASEB J; 2010 Apr; 24(4):1023-34. PubMed ID: 19940258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laquinimod enhances central nervous system barrier functions.
    Lühder F; Kebir H; Odoardi F; Litke T; Sonneck M; Alvarez JI; Winchenbach J; Eckert N; Hayardeny L; Sorani E; Lodygin D; Flügel A; Prat A
    Neurobiol Dis; 2017 Jun; 102():60-69. PubMed ID: 28235673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of central nervous system barriers in multiple sclerosis.
    Alvarez JI; Cayrol R; Prat A
    Biochim Biophys Acta; 2011 Feb; 1812(2):252-64. PubMed ID: 20619340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.